A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor.
Qiu S, Liu N, Jia L, Yang G, Su W, Li J, Song L, Yang C, Wang J, Zhang C, Wang Z, Qiao F, Tomlinson S, Atkinson C, Sun Y, Huang L, Song H, Wang Y, Li Z.
Qiu S, et al. Among authors: atkinson c.
Virol J. 2012 Nov 23;9:285. doi: 10.1186/1743-422X-9-285.
Virol J. 2012.
PMID: 23173749
Free PMC article.